Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Viktor Rotbain-Curovic"'
Autor:
Peter Rossing, Simone Theilade, Christian Stevns Hansen, Marie Frimodt-Moller, Viktor Rotbain Curovic, Tine W Hansen, Cristina Legido-Quigley, Nete Tofte, Tarunveer S Ahluwalia, Ismo Matias Mattila, Brede A Sørland, Siddhi Y Jain, Karolina Sulek, Kajetan Trost, Signe Abitz Winther
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 2 (2024)
Introduction Diabetic retinopathy (DR), diabetic kidney disease (DKD) and distal symmetric polyneuropathy (DSPN) share common pathophysiology and pose an additive risk of early mortality.Research design and methods In adults with type 1 diabetes, 49
Externí odkaz:
https://doaj.org/article/1af062286c6c4c5eac1dbe7151d7f537
Autor:
Asger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, Tommi Suvitaival, Jin Xu, Emilie Hein Zobel, Bernt Johan von Scholten, Rasmus Sejersten Ripa, Andreas Kjaer, Tine Willum Hansen, Tina Vilsbøll, Henrik Vestergaard, Peter Rossing, Cristina Legido-Quigley
Publikováno v:
Lipids in Health and Disease, Vol 22, Iss 1, Pp 1-12 (2023)
Abstract Background Specific ceramides have been identified as risk markers for cardiovascular disease (CVD) years before onset of disease. Treatment with the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide has been shown to induce ben
Externí odkaz:
https://doaj.org/article/81dad782fa1040f5abe1e046c103c5d3
Autor:
Luis F. Ferreira-Divino, Tommi Suvitaival, Viktor Rotbain Curovic, Nete Tofte, Kajetan Trošt, Ismo M. Mattila, Simone Theilade, Signe A. Winther, Tine W. Hansen, Marie Frimodt-Møller, Cristina Legido-Quigley, Peter Rossing
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background Cardiovascular disease remains the leading cause of mortality in individuals with diabetes and improved understanding of its pathophysiology is needed. We investigated the association of a large panel of metabolites and molecular
Externí odkaz:
https://doaj.org/article/389bfe119996400782c26301fc940633
Autor:
Emilie H. Zobel, Rasmus S. Ripa, Bernt J. von Scholten, Viktor Rotbain Curovic, Andreas Kjaer, Tine W. Hansen, Peter Rossing, Joachim Størling
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Anti-inflammatory effects of glucagon-like peptide 1 receptor agonist (GLP-1 RA) treatment in T2D may contribute to the cardiovascular benefits observed with GLP-1 RAs in outcome studies. We investigated if the GLP-1 RA liraglutide exerts an
Externí odkaz:
https://doaj.org/article/44a015485b9644c7a5d5d44744afea42
Autor:
Viktor Rotbain Curovic, Morten B. Houlind, Tine W. Hansen, Jesper Eugen-Olsen, Jens Christian Laursen, Mie K. Eickhoff, Frederik Persson, Peter Rossing
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Elevated soluble urokinase plasminogen activator receptor (suPAR) is highly associated with increased risk of diabetic complications. Dapagliflozin is a drug inhibiting the sodium-glucose co-transporter 2 in the kidney to decrease blood g
Externí odkaz:
https://doaj.org/article/566f5b4cc054458fb0059e50badd6cf6
Autor:
Asger Wretlind, Emilie Hein Zobel, Andressa de Zawadzki, Rasmus Sejersten Ripa, Viktor Rotbain Curovic, Bernt Johan von Scholten, Ismo Matias Mattila, Tine Willum Hansen, Andreas Kjær, Henrik Vestergaard, Peter Rossing, Cristina Legido-Quigley
Publikováno v:
Frontiers in Clinical Diabetes and Healthcare, Vol 3 (2022)
BackgroundLiraglutide is a glucose-lowering medication used to treat type 2 diabetes and obesity. It is a GLP-1 receptor agonist with downstream metabolic changes beyond the incretin system, such as reducing the risk of cardiovascular complications.
Externí odkaz:
https://doaj.org/article/9a83d2ed45e7427bba080f2aa328deb5
Autor:
Jacob K. Jensen, Emilie H. Zobel, Bernt J. von Scholten, Viktor Rotbain Curovic, Tine W. Hansen, Peter Rossing, Andreas Kjaer, Rasmus S. Ripa
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
BackgroundQuantification of coronary artery inflammation and atherosclerosis remains a challenge in high-risk individuals. In this study we sought to investigate if the glucagon like peptide-1 receptor agonist liraglutide has a direct anti-inflammato
Externí odkaz:
https://doaj.org/article/85c1b16bc6ce4583a9afe49ce90637c0
Autor:
Andreas Kjær, Peter Rossing, Emilie H Zobel, Asger Wretlind, Rasmus S Ripa, Viktor Rotbain Curovic, Bernt J von Scholten, Tommi Suvitaival, Tine W Hansen, Cristina Legido-Quigley
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 9, Iss 1 (2021)
Externí odkaz:
https://doaj.org/article/cccfc22306d64967a2e1646bd7183cb0
Autor:
Viktor Rotbain Curovic, Niels Jongs, Marjolein Y.A.M. Kroonen, Emilie H. Zobel, Tine W. Hansen, Taha Sen, Gozewijn D. Laverman, Adriaan Kooy, Frederik Persson, Peter Rossing, Hiddo J.L. Heerspink
Publikováno v:
Diabetes Care. 46:593-601
OBJECTIVERenin–angiotensin system (RAS) inhibitors decrease the urinary albumin to creatinine ratio (UACR) but are ineffective in up to 40% of patients. We hypothesized that rotation through different drug classes overcomes RAS inhibitor resistance
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dd56d3c9208ecb284ab86e915011941c
https://doi.org/10.2337/dc22-1699
https://doi.org/10.2337/dc22-1699
Autor:
Emilie H. Zobel, Rasmus S. Ripa, Bernt J. von Scholten, Viktor Rotbain Curovic, Lars Jorge Diaz, Tine W. Hansen, Peter Rossing, Andreas Kjaer
Publikováno v:
Diagnostics, Vol 11, Iss 8, p 1431 (2021)
Quantification of vascular inflammation before and after treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) may help reveal mechanistic pathways underlying the cardiovascular benefits of these drugs. We assessed change in vascular i
Externí odkaz:
https://doaj.org/article/63e6a65ecd3549c9bb602b7c6cba2872